These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9821965)

  • 21. Towards new thymidine phosphorylase/PD-ECGF inhibitors based on the transition state of the enzyme reaction.
    Priego EM; Mendieta J; Gago F; Balzarini J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):951-3. PubMed ID: 14565319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of TNP-470, a potent angiogenesis inhibitor, on growth of hematopoietic progenitors.
    Hasuike T; Hino M; Yamane T; Nishizawa Y; Morii H; Tatsumi N
    Eur J Haematol; 1997 Apr; 58(4):293-4. PubMed ID: 9186544
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.
    Shahzad SA; Sarfraz A; Yar M; Khan ZA; Naqvi SAR; Naz S; Khan NA; Farooq U; Batool R; Ali M
    Bioorg Chem; 2020 Jul; 100():103876. PubMed ID: 32388426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.
    Almandil NB; Taha M; Farooq RK; Alhibshi A; Ibrahim M; Anouar EH; Gollapalli M; Rahim F; Nawaz M; Shah SAA; Ahmed QU; Zakaria ZA
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30871147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.
    Shahzad SA; Yar M; Khan ZA; Shahzadi L; Naqvi SAR; Mahmood A; Ullah S; Shaikh AJ; Sherazi TA; Bale AT; Kukułowicz J; Bajda M
    Bioorg Chem; 2019 Apr; 85():209-220. PubMed ID: 30634096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, thymidine phosphorylase, angiogenic inhibition and molecular docking study of isoquinoline derivatives.
    Zaman K; Rahim F; Taha M; Wadood A; Adnan Ali Shah S; Gollapalli M; Ullah F; Ahmed A
    Bioorg Chem; 2019 Aug; 89():102999. PubMed ID: 31151055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening.
    McNally VA; Gbaj A; Douglas KT; Stratford IJ; Jaffar M; Freeman S; Bryce RA
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3705-9. PubMed ID: 14552762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
    Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
    Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.
    Desgranges C; Razaka G; Rabaud M; Bricaud H; Balzarini J; De Clercq E
    Biochem Pharmacol; 1983 Dec; 32(23):3583-90. PubMed ID: 6651877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.
    Zhao S; Li K; Jin Y; Lin J
    Eur J Med Chem; 2018 Jan; 144():41-51. PubMed ID: 29247859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives.
    Taha M; Adnan Ali Shah S; Afifi M; Imran S; Sultan S; Rahim F; Hadiani Ismail N; Mohammed Khan K
    Bioorg Chem; 2018 Aug; 78():17-23. PubMed ID: 29525348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
    Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants.
    Gbaj A; Edwards PN; Reigan P; Freeman S; Jaffar M; Douglas KT
    J Enzyme Inhib Med Chem; 2006 Feb; 21(1):69-73. PubMed ID: 16570508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.
    Murray PE; McNally VA; Lockyer SD; Williams KJ; Stratford IJ; Jaffar M; Freeman S
    Bioorg Med Chem; 2002 Mar; 10(3):525-30. PubMed ID: 11814838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors.
    Khan KM; Ambreen N; Hussain S; Perveen S; Choudhary MI
    Bioorg Med Chem; 2009 Apr; 17(8):2983-8. PubMed ID: 19329330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
    Casanova E; Hernandez AI; Priego EM; Liekens S; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Sep; 49(18):5562-70. PubMed ID: 16942029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
    Pérez-Pérez MJ; Priego EM; Hernández AI; Camarasa MJ; Balzarini J; Liekens S
    Mini Rev Med Chem; 2005 Dec; 5(12):1113-23. PubMed ID: 16375757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.